MTOR and breast cancer: Importantly, RET expression in breast cancer is also correlated with resistance to endocrine therapies via stimulation of the mTOR signaling pathway (Plaza-Menacho et al., 2010; Gattelli et al., 2013; Morandi et al., 2013).